Clinical Trial - Trial ChiCTR2200061108
Access comprehensive clinical trial information for ChiCTR2200061108 through Pure Global AI's free database. This Phase 4 trial is sponsored by Peking University People’s Hospital and is currently Not yet recruiting. The study focuses on lung cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
ChiCTR2200061108
Phase 4
Not yet recruiting
Trial Details
Chinese Clinical Trial Registry • ChiCTR2200061108
View on Chinese Clinical Trial Registry
Untitled Trial
A Randomized Controlled Clinical Study to Explore the Clinical Value of MRD Monitoring for Adjuvant Targeted Therapy
Study Focus
Sponsor & Location
Peking University People’s Hospital
China
Timeline & Enrollment
Phase 4
N/A
Jul 31, 2029
ICD-10 Classifications
Carcinoma in situ: Bronchus and lung
Secondary malignant neoplasm of lung
Malignant neoplasm of bronchus and lung
Malignant neoplasm: Bronchus or lung, unspecified
Malignant neoplasm: Overlapping lesion of bronchus and lung
Data Source
Chinese Clinical Trial Registry
ChiCTR2200061108
Non-Device Trial